225 related articles for article (PubMed ID: 28395806)
1. Generation of human iPSCs from an essential thrombocythemia patient carrying a V501L mutation in the MPL gene.
Liu S; Ye Z; Gao Y; He C; Williams DW; Moliterno A; Spivak J; Huang H; Cheng L
Stem Cell Res; 2017 Jan; 18():57-59. PubMed ID: 28395806
[TBL] [Abstract][Full Text] [Related]
2. Generation of induced pluripotent stem cells from peripheral blood CD34+ hematopoietic progenitors of a 31year old healthy woman.
Tangprasittipap A; Jittorntrum B; Wongkummool W; Kitiyanant N; Tubsuwan A
Stem Cell Res; 2017 Apr; 20():91-93. PubMed ID: 28395748
[TBL] [Abstract][Full Text] [Related]
3. Generation of non-integrated induced pluripotent stem cells from a 59-year-old female with multiple endocrine neoplasia type 1 syndrome.
Guo D; Wu F; Liu H; Gao G; Kou S; Yang F; Abbas N; Zhou T; Cai X; Zhang H; Qin D; Li J; Xu K; Li YX
Stem Cell Res; 2017 Jan; 18():64-66. PubMed ID: 28395808
[TBL] [Abstract][Full Text] [Related]
4. Generation of an iPSC line from a patient with GTP cyclohydrolase 1 (GCH1) deficiency: HDMC0061i-GCH1.
Jung-Klawitter S; Ebersold J; Göhring G; Blau N; Opladen T
Stem Cell Res; 2017 Apr; 20():38-41. PubMed ID: 28395739
[TBL] [Abstract][Full Text] [Related]
5. Derivation of the human induced pluripotent stem cell line MUi017-A from a patient with homozygous Hemoglobin Constant Spring.
Wongkummool W; Maneepitasut W; Munkongdee T; Tong-Ngam P; Tangprasittipap A; Svasti S; Kitiyanant N; Paiboonsukwong K; Fucharoen S; Tubsuwan A
Stem Cell Res; 2017 Apr; 20():84-87. PubMed ID: 28395746
[TBL] [Abstract][Full Text] [Related]
6. Derivation of induced pluripotent stem cells from a familial Alzheimer's disease patient carrying the L282F mutation in presenilin 1.
Poon A; Li T; Pires C; Nielsen TT; Nielsen JE; Holst B; Dinnyes A; Hyttel P; Freude KK
Stem Cell Res; 2016 Nov; 17(3):470-473. PubMed ID: 27789396
[TBL] [Abstract][Full Text] [Related]
7. Generation of human iPSCs from urine derived cells of a non-affected control subject.
Afzal MZ; Gartz M; Klyachko EA; Khan SS; Shah SJ; Gupta S; Shapiro AD; Vaughan DE; Strande JL
Stem Cell Res; 2017 Jan; 18():33-36. PubMed ID: 28395799
[TBL] [Abstract][Full Text] [Related]
8. Generation and characterization of two iPSC lines from human epicardium-derived cells.
Paulitschek C; Schulze-Matz P; Hesse J; Schmidt T; Wruck W; Adjaye J; Schrader J
Stem Cell Res; 2017 Apr; 20():50-53. PubMed ID: 28395740
[TBL] [Abstract][Full Text] [Related]
9. Generation of an iPSC line from a patient with tyrosine hydroxylase (TH) deficiency: TH-1 iPSC.
Jung-Klawitter S; Blau N; Sebe A; Ebersold J; Göhring G; Opladen T
Stem Cell Res; 2016 Nov; 17(3):580-583. PubMed ID: 27934587
[TBL] [Abstract][Full Text] [Related]
10. Generation of a human induced pluripotent stem cell (iPSC) line carrying the Parkinson's disease linked LRRK2 variant S1647T.
Ma D; Ng SH; Zeng L; Zhao Y; Tan EK
Stem Cell Res; 2017 Jan; 18():54-56. PubMed ID: 28395805
[TBL] [Abstract][Full Text] [Related]
11. Generation of a human induced pluripotent stem cell (iPSC) line from a patient with family history of diabetes carrying a C18R mutation in the PDX1 gene.
Wang X; Chen S; Burtscher I; Sterr M; Hieronimus A; Machicao F; Staiger H; Häring HU; Lederer G; Meitinger T; Lickert H
Stem Cell Res; 2016 Sep; 17(2):292-295. PubMed ID: 27879214
[TBL] [Abstract][Full Text] [Related]
12. Creating a patient carried Men1 gene point mutation on wild type iPSCs locus mediated by CRISPR/Cas9 and ssODN.
Guo D; Liu H; Gao G; Liu Y; Zhuang Y; Yang F; Wang K; Zhou T; Qin D; Hong L; Li J; Xu K; Li YX
Stem Cell Res; 2017 Jan; 18():67-69. PubMed ID: 28395809
[TBL] [Abstract][Full Text] [Related]
13. Generation of MERRF patient-derived induced pluripotent stem cell line iMERRF-C7.
Liang D; Hu H; Xu T; Wang Y; Hu P; Xu Z
Stem Cell Res; 2016 Nov; 17(3):616-618. PubMed ID: 27934592
[TBL] [Abstract][Full Text] [Related]
14. Characterization of dermal fibroblast-derived iPSCs from a patient with low grade steatosis.
Kawala MA; Bohndorf M; Graffmann N; Wruck W; Zatloukal K; Adjaye J
Stem Cell Res; 2016 Nov; 17(3):547-549. PubMed ID: 27789406
[TBL] [Abstract][Full Text] [Related]
15. Generation of HEXA-deficient hiPSCs from fibroblasts of a Tay-Sachs disease patient.
Liu Z; Zhao R
Stem Cell Res; 2016 Sep; 17(2):289-291. PubMed ID: 27879213
[TBL] [Abstract][Full Text] [Related]
16. Reprogramming of a human induced pluripotent stem cell (iPSC) line from a Parkinson's disease patient with a R1628P variant in the LRRK2 gene.
Ma D; Zhou W; Ng EY; Zeng L; Zhao Y; Tan EK
Stem Cell Res; 2017 Jan; 18():45-47. PubMed ID: 28395802
[TBL] [Abstract][Full Text] [Related]
17. Generation of human iPSCs from urine derived cells of patient with a novel heterozygous PAI-1 mutation.
Afzal MZ; Gartz M; Klyachko EA; Khan SS; Shah SJ; Gupta S; Shapiro AD; Vaughan DE; Strande JL
Stem Cell Res; 2017 Jan; 18():41-44. PubMed ID: 28395801
[TBL] [Abstract][Full Text] [Related]
18. Development of a human induced pluripotent stem cell (iPSC) line from a Parkinson's disease patient carrying the N551K variant in LRRK2 gene.
Ma D; Ng EY; Zeng L; Lim CY; Zhao Y; Tan EK
Stem Cell Res; 2017 Jan; 18():51-53. PubMed ID: 28395804
[TBL] [Abstract][Full Text] [Related]
19. Establishment of MUi009 - A human induced pluripotent stem cells from a 32year old male with homozygous β°-thalassemia coinherited with heterozygous α-thalassemia 2.
Wongkummool W; Maneepitasut W; Tong-Ngam P; Tangprasittipap A; Munkongdee T; Boonchuay C; Svasti S; Kitiyanant N; Paiboonsukwong K; Fucharoen S; Tubsuwan A
Stem Cell Res; 2017 Apr; 20():80-83. PubMed ID: 28395745
[TBL] [Abstract][Full Text] [Related]
20. Induced pluripotent stem cells (iPSCs) derived from cerebrotendinous xanthomatosis (CTX) patient's fibroblasts carrying a R395S mutation.
Höflinger P; Hauser S; Theurer Y; Weißenberger S; Wilke C; Schöls L
Stem Cell Res; 2016 Sep; 17(2):433-436. PubMed ID: 27879219
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]